Metis TechBio’s retail tranche oversubscribed 5 times

Metis TechBio, one of the Three Little Dragons of AI Drug Discovery, oversubscribed its retail tranche by 5 times in its Hong Kong initial public offering on Tuesday.

The company has drawn HK$640 million in margin loans. It plans to offer 200 million H shares at an offer price of HK$10.5 per share, raising HK$2.11 billion. Each board lot of 500 shares has an entry fee of HK$5,303.

Its scheduled debut date is on May 13.
 

 

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗧𝗵𝗲 𝗦𝘁𝗮𝗻𝗱𝗮𝗿𝗱 𝗔𝗽𝗽 ↓